Anidro do Brasil (Centroflora)
Brazil
Hybrid — also manufactures internal programs
Program data pending ClinicalTrials.gov matching
Profiled
Not yet scored
✓ FDA Inspections (1)
○ Clinical Trials
○ SEC Filings
○ Press
○ EMA GMP
✓ MHRA GMP (2)
✓ HC GMP (1)
Quick Facts: Anidro do Brasil (Centroflora)
- Signal Score
- Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works
- Headquarters
- Brazil
- Website
- https://www.centroflora.com.br/en/
- Modalities
- Small Molecule API
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
About Anidro do Brasil (Centroflora)
Anidro do Brasil (Centroflora) makes its own pharmaceutical products and also offers contract development and manufacturing services. Capabilities: Small Molecule API. 1 manufacturing site registered with the U.S. FDA, the UK MHRA and Health Canada. Website: https://www.centroflora.com.br/en/
Signal Score
Profiled, not yet scored.
Scores are published after regulatory evidence is attached and reviewed.
How scoring works
Anidro do Brasil (Centroflora) FDA Inspection History
2024-11
NAI
VAI
OAI
| Date | Site | Type | Observations | Classification |
|---|---|---|---|---|
| 2024-11-15 |
Anidro Do Brasil Extracoes S.A.
Parnaiba
Company-level
|
Drug Quality Assurance | No | Voluntary Action Indicated (VAI) |
Source: FDA Data Dashboard · Retrieved Oct 31, 2026
Anidro do Brasil (Centroflora) MHRA GMP Compliance 2 certificates
2014-03
2014-03
Compliant
Non-Compliant
| Certificate | Site | City / Postcode | Inspection Date | Status |
|---|---|---|---|---|
| UK API 43175 Insp GMP 43175/9985247-0001 [H] | ANIDRO DO BRASIL EXTRACOES SA | BR-64216 815 | 2014-03-10 | COMPLIANT |
| UK API 43175 Insp GMP 43175/9985247-0001 [V] | ANIDRO DO BRASIL EXTRACOES SA | BR-64216 815 | 2014-03-10 | COMPLIANT |
Source: MHRA GMDP Database · Retrieved Oct 31, 2026
Hiring Activity Beta
Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No hiring data yet. We haven't found a public jobs feed for this company.
Source:
public careers pages
· Checked Oct 30, 2026
Frequently Asked Questions About Anidro do Brasil (Centroflora)
How many FDA inspections does Anidro do Brasil (Centroflora) have on record?
CDMO Signal tracks 1 FDA inspection for Anidro do Brasil (Centroflora), sourced from the FDA inspection database. See the full inspection history above.
Has Anidro do Brasil (Centroflora) received an FDA warning letter?
CDMO Signal has no FDA warning letters on record for Anidro do Brasil (Centroflora).
Does Anidro do Brasil (Centroflora) hold EMA or MHRA GMP certificates?
CDMO Signal tracks 2 MHRA GMP certificates for Anidro do Brasil (Centroflora).
Does Anidro do Brasil (Centroflora) have a CDMO Signal Score?
Not yet. Anidro do Brasil (Centroflora) is profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed.
Evaluating Anidro do Brasil (Centroflora) for a manufacturing program?
Use the free AI matchmaker to compare Anidro do Brasil (Centroflora) against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
Similar CDMOs
Olon
Rodano (Milano), Italy
Small Molecule API, Biologics, ADC / Bioconjugation
Sterling Pharma Solutions
Cramlington, United Kingdom
Small Molecule API, High-Potency APIs, Peptides, ADC / Bioconjugation, Controlled Substances, Clinical Trial Manufacturing
Veranova
United States
Small Molecule API, ADC / Bioconjugation
Sai Life Sciences
India
Small Molecule API
EUROAPI
France
Small Molecule API, Oligonucleotide, Peptides, Lipids, Microbial Fermentation, Particle Engineering
Compare Anidro do Brasil (Centroflora) with another CDMO
Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.